Coulter Partners secures CEO Placement for NeoPhore
22 Jan 2025 //
PHARMAWEB
NeoPhore appoints Michael Shih as Chief Executive Officer
16 Dec 2024 //
PR NEWSWIRE
NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension
01 Feb 2024 //
PR NEWSWIRE
NeoPhore signs research collaboration with The Institute of Cancer Research
18 Apr 2023 //
PR NEWSWIRE